• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Ontrak Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    9/19/24 9:01:45 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care
    Get the next $OTRK alert in real time by email
    cats-20240917
    12/310001136174FALSE00011361742024-09-172024-09-17

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported):  September 17, 2024

    Ontrak, Inc.
    (Exact name of registrant as specified in its charter)
    Delaware001-3193288-0464853
    (State or other jurisdiction
    of incorporation)
    (Commission File Number)(IRS Employer
    Identification No.)

    333 S. E. 2nd Avenue, Suite 2000, Miami, FL 33131
    (Address of principal executive offices) (Zip Code)

    Registrant’s telephone number, including area code   (310) 444-4300


    (Former name or former address, if changed since last report.)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

    ☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, $0.0001 par valueOTRK
    The NASDAQ Capital Market


    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company  ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐





    Item 3.03. Material Modification to Rights of Security Holders.

    To the extent required by Item 3.03 of Form 8-K, the information in Item 5.03 of this report is incorporated herein by reference.

    Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

    As previously reported in its Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on September 13, 2024, Ontrak, Inc. (“we,” “us,” “our” or the “Company”) held its annual meeting of stockholders on September 10, 2024 at which the Company’s stockholders approved the proposal to give the Company’s board of directors (the “Board”) the authority, at its discretion, to file a certificate of amendment to the Company’s certificate of incorporation to effect a reverse split of the Company’s issued common stock (the “Common Stock”), at a ratio not less than 1-for-2 and not greater than 1-for-15, without reducing the authorized number of shares of Common Stock, with the exact ratio to be selected by the Board in its discretion and to be effected, if at all, in the sole discretion of the Board at any time following stockholder approval of the proposal and before September 10, 2025 without further approval or authorization of the Company’s stockholders.

    Subsequently, the Board determined to effect a reverse split of the Common Stock (the “Reverse Stock Split”) at a ratio of 1-for-15 (the “Reverse Stock Split Ratio”).

    On September 17, 2024, the Company filed a certificate of amendment to the Company’s certificate of incorporation with the Secretary of State of the State of Delaware to effect the Reverse Stock Split (the “Charter Amendment”). The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on September 23, 2024, and the Common Stock is expected to begin trading on a split-adjusted basis at the opening of trading on The Nasdaq Capital Market on September 23, 2024. The Common Stock will continue to trade under its existing symbol “OTRK,” but the Common Stock has been assigned a new CUSIP number (683373 401).

    When the Reverse Stock Split becomes effective, every 15 shares of Common Stock issued, including shares held by the Company in treasury, if any, will automatically be reclassified and combined into one share of Common Stock. No fractional shares will be issued as a result of the Reverse Stock Split. Stockholders who would otherwise be entitled to receive a fractional share will instead automatically have their fractional interests rounded up to the next whole share, after aggregating the fractional interests of a holder resulting from the Reverse Stock Split. The Reverse Stock Split will affect all stockholders uniformly and will not change any stockholder’s percentage ownership interest or any stockholder’s proportionate voting power, except for changes that may result from the treatment of fractional shares. The Reverse Stock Split will not change the number of authorized shares of Common Stock or the par value per share of the Common Stock.

    The Reverse Stock Split will reduce the number of issued and outstanding shares of Common Stock from approximately 48.0 million to approximately 3.2 million.

    In addition, as a result of the Reverse Stock Split, proportionate adjustments will made in accordance with the applicable terms of outstanding securities and the Company’s stock incentive plans to the (a) per share exercise prices of, and the number of shares underlying, the Company’s outstanding stock options, (b) number of shares available for the grant of awards under the Company’s stock incentive plans, and (c) per share exercise prices of, and the number of shares underlying, outstanding warrants to purchase shares of the Company’s common stock.

    The foregoing description of the Charter Amendment does not purport to be complete and is qualified in its entirety by reference to the full text thereof, which is filed as an exhibit to this report and is incorporated herein by reference.

    Item 7.01 Regulation FD Disclosure.

    On September 19, 2024, the Company issued a press release announcing the Reverse Stock Split, a copy of which is furnished as an exhibit to this report.

    The information in this Item 7.01, including Exhibit 99.1 to this report, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). The information contained in this Item 7.01 and Exhibit 99.1 shall not be incorporated by reference into any filing under the Exchange Act or the Securities Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.


    1


    Item 8.01 Other Events.

    The information in Item 5.03 of report is incorporated herein by reference.

    The Company has registration statements on Form S-3 (File Nos. 333-121634, 333-123772, 333-128544, 333-128931, 333-140114, 333-140593, 333-140594, 333-145906, 333-147188, 333-153053, 333-158407, 333-230475, 333-248770, and 333-259329) and registration statements on Form S-8 (File Nos. 333-282112, 333-278847, 333-269341, 333-268928, 333-267316, 333-266467, 333-263942, 333-261976, 333-251965, 333-237566, 333-229717, 333-229117, 333-222276, 333-173662, 333-153054, 333-149766, 333-136446, and 333-123773) on file with the SEC (collectively, the “Registration Statements”). SEC regulations permit the Company to incorporate by reference future filings made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offerings covered by registration statements filed on Form S-3 and/or Form S-8. The information incorporated by reference is considered part of the prospectus included within each of those registration statements. Information in this Item 8.01 is intended to be automatically incorporated by reference into each of the active Registration Statements, thereby amending them. Pursuant to Rule 416(b) under the Securities Act of 1933, as amended, the amount of undistributed shares of Common Stock deemed covered by the Registration Statements are proportionately reduced as of the effective time of the Reverse Stock Split at the Reverse Stock Split Ratio.


    Item 9.01 Financial Statements and Exhibits.

    (d) Exhibits.

    Exhibit No.
    Description
    3.1
    Certificate of Amendment of Certificate of Incorporation dated September 17, 2024
    99.1
    Press release issued on September 19, 2024
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document).








    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Ontrak, Inc.
    Date: September 19, 2024By:/s/ James J. Park
    James J. Park
    Chief Financial Officer



    2
    Get the next $OTRK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OTRK

    DatePrice TargetRatingAnalyst
    12/5/2023$4.00Buy
    ROTH MKM
    3/9/2022$13.00 → $2.50Hold
    Canaccord Genuity
    3/9/2022$11.00 → $2.00Sector Perform
    RBC Capital
    8/20/2021$35.00 → $9.00Market Perform → Underperform
    Cowen & Co.
    8/20/2021$15.00Buy → Neutral
    B. Riley Securities
    More analyst ratings

    $OTRK
    SEC Filings

    View All

    Ontrak Inc. filed SEC Form 8-K: Other Events, Leadership Update

    8-K - Ontrak, Inc. (0001136174) (Filer)

    8/28/25 4:32:50 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form NT 10-Q filed by Ontrak Inc.

    NT 10-Q - Ontrak, Inc. (0001136174) (Filer)

    8/15/25 6:36:38 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Ontrak, Inc. (0001136174) (Filer)

    8/13/25 4:13:55 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    $OTRK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Electronic Data Interchange Market Size to Grow USD 74.36 billion by 2031, Rising Digital Transformation Across Various Industries Propels | The Insight Partners

    NEW YORK, July 21, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the electronic data interchange (EDI) market is observing significant growth owing to the rising digital transformation across various industries and the growing adoption of EDI in small and medium enterprises. The electronic data interchange market was valued at US$34.02 billion in 2024 and is projected to reach US$74.36 billion by 2031; it is expected to register a CAGR of 11.9% during 2025-2031.  The electronic data interchange market comprises an array of components a

    7/21/25 11:30:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health Announces Pricing of $4 Million Public Offering

    Ontrak, Inc. (NASDAQ:OTRK), a leading value-based behavioral healthcare company powered by proprietary AI and engagement technology, today announced the pricing of a public offering of 6,666,667 shares of its common stock (or pre-funded warrants in lieu thereof) and 26,666,668 warrants to purchase up to 26,666,668 shares of its common stock at a combined public offering price of $0.60 per share of common stock and accompanying warrants or at a combined public offering price of $0.5999 per pre-funded warrant and accompanying warrants, which represents the per share public offering price for the common stock and accompanying warrants less the $0.0001 per share exercise price for each pre-fund

    6/27/25 8:30:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health Announces Expansion of Engage Solution for Sentara Health Plans Self-funded Employer Customers

    Ontrak, Inc. (NASDAQ:OTRK), a leading value-based behavioral healthcare company powered by proprietary AI and engagement technology, today announced an expanded partnership with Sentara Health Plans to offer Ontrak's Engage Solution to employer sponsored customers in the Commonwealth of Virginia. Sentara Health Plans is the health plan division of Sentara Health, an integrated, not-for-profit health care delivery system that provides health plan coverage to one million members in Virginia and Florida. Sentara offers programs to support members with chronic illnesses, customized wellness programs, and integrated clinical and behavioral health services—all to help members improve their heal

    6/24/25 8:00:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    $OTRK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Peizer Terren S exercised 500,000 in-the-money shares at a strike of $0.00 (SEC Form 4)

    4 - Ontrak, Inc. (0001136174) (Issuer)

    6/24/25 6:32:14 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Large owner Peizer Terren S

    4 - Ontrak, Inc. (0001136174) (Issuer)

    6/23/25 8:06:38 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Chief Financial Officer Park James J converted options into 4 shares and covered exercise/tax liability with 1 shares, increasing direct ownership by 33% to 12 units (SEC Form 4)

    4 - Ontrak, Inc. (0001136174) (Issuer)

    6/17/25 5:33:52 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    $OTRK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    ROTH MKM initiated coverage on Ontrak with a new price target

    ROTH MKM initiated coverage of Ontrak with a rating of Buy and set a new price target of $4.00

    12/5/23 8:03:01 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Canaccord Genuity reiterated coverage on Ontrak with a new price target

    Canaccord Genuity reiterated coverage of Ontrak with a rating of Hold and set a new price target of $2.50 from $13.00 previously

    3/9/22 9:09:19 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    RBC Capital reiterated coverage on Ontrak with a new price target

    RBC Capital reiterated coverage of Ontrak with a rating of Sector Perform and set a new price target of $2.00 from $11.00 previously

    3/9/22 7:43:55 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    $OTRK
    Leadership Updates

    Live Leadership Updates

    View All

    Ontrak Names James Messina to its Board of Directors

    Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of James Messina as a non-Executive Director to its board. Mr. Messina is a Co-Founder and General Partner of Seattle Hill Ventures and x4 Capital Partners, which invest in, and support, startup ventures by providing business development, marketing, operating and technology support. Previously, Mr. Messina was the Executive Vice President and Chief Operating Officer for Premera Blue Cross ("Premera"). He was responsible for effectively servicing the needs of Premera's customers with oversight of all operational functions, from customer serv

    8/30/22 8:00:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Names Dr. Robert Accordino Chief Medical Officer

    Mental Healthcare Leader and Harvard Medical School Faculty Member Joins Ontrak Ontrak, Inc (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of Dr. Robert Accordino as Ontrak's Chief Medical Officer, effective September 27, 2021. Dr. Accordino joins Ontrak from Quartet Health where he served as the company's most senior clinician and Chief Mental Health Officer. He practices psychiatry and is on the faculty of Harvard Medical School and Massachusetts General Hospital. Dr. Accordino will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS Health earlier this year. "Dr. Accordino's reputation in

    9/9/21 8:00:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Arik Hill Joins Ontrak as Chief Information Officer

    Former Accenture and KPMG Healthcare Expert Brings Proven Leadership Experience In Behavioral Health Digital Transformation Ontrak, Inc (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of Arik Hill as Ontrak's first Chief Information Officer, effective August 30, 2021. Mr. Hill will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS Health earlier this year. "As Chief Information Officer at The New York Foundling, a fast growing organization that collaborates with over 250,000 behavioral healthcare partners across the country, Arik led the development of digital platforms and applications th

    8/12/21 8:00:00 AM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    $OTRK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ontrak Inc.

    SC 13G/A - Ontrak, Inc. (0001136174) (Subject)

    11/14/24 4:24:03 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Ontrak Inc.

    SC 13D/A - Ontrak, Inc. (0001136174) (Subject)

    10/3/24 6:37:08 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Ontrak Inc.

    SC 13D/A - Ontrak, Inc. (0001136174) (Subject)

    8/30/24 5:15:15 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    $OTRK
    Financials

    Live finance-specific insights

    View All

    Ontrak Health Announces 2025 First Quarter Financial Results

    Q1 Revenue of $2.0 million, down 25% year over year Q1 Operating loss of $(5.9) million, a 37% increase year over year Q1 Adjusted EBITDA of $(4.3) million, a 28% decline year over year Company announces securing a $10.0 million financing commitment from Acuitas Capital LLC Company announces recertification by the National Committee for Quality Assurance (NCQA) as a Credentials Verification Organization (CVO) Company to Host Conference Call at 4:30 pm ET Today Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technology-enabled behavioral healthcare company, today reported its financial results for the first quarter ended March 31, 2025. Manageme

    5/20/25 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health to Report 2025 First Quarter Financial Results on May 20, 2025

    Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the first quarter 2025 on Tuesday, May 20, 2025, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events . Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes before

    5/19/25 4:30:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care

    Ontrak Health to Report 2024 Fourth Quarter Financial Results on April 14, 2025

    Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the fourth quarter 2024 on Monday, April 14, 2025, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/delivering-a-healthier-future-for-all/presentations-events/. Participants interested in dialing in to the conference call are requested to register a day in advance or

    4/10/25 4:05:00 PM ET
    $OTRK
    Misc Health and Biotechnology Services
    Health Care